MedPath

Clinical study to find the effect of Takra basti for duration of 8 days along with panchamruta parpati in the management of irritable bowel syndrome (I.B.S.)

Phase 2
Not yet recruiting
Conditions
Intestinal malabsorption, unspecified. Ayurveda Condition: GRAHANIDOSHAH,
Registration Number
CTRI/2021/04/032523
Lead Sponsor
dr d y patil patil vidyapeeth pune
Brief Summary

30 patients will be taken for clinical trial

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

patients with irritable bowel syndrome.

Exclusion Criteria

patients suffering from any other systemic disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relieving signs and symptoms of Irritable Bowel Syndromebefore start of trial and end of trial i.e. on 1st day and 8th day of trial
Secondary Outcome Measures
NameTimeMethod
standardized the Takra Basti procedureat start of trial and end of trial i.e. on 1st day and 8th day of trial

Trial Locations

Locations (1)

dr d y patil vidyapeeth pune

🇮🇳

Pune, MAHARASHTRA, India

dr d y patil vidyapeeth pune
🇮🇳Pune, MAHARASHTRA, India
dr mamata nakade
Principal investigator
9850241887
mamta.nakade@dpu.edu.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.